Szívelégtelenség: vizsgálatok itt: Finnország
14 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- No phaseTaking peopleProduct Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Where
- Helsinki
- People
- 20 000 worldwide
- Run by
- Medtronic
See details and how to joinNCT00271180 - 2/3. fázisTaking peopleEfficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
- Where
- Tampere
- Életkor
- 29 nap to 17 év
- People
- 342 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05714085 · EU 2022-501238-52-00 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Where
- Helsinki, Jyväskylä, Kuopio, Turku
- Életkor
- 18 év to 99 év
- People
- 5056 worldwide
- Run by
- Amgen
See details and how to joinNCT07037459 - 3. fázisTaking peopleMaridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
- Where
- Helsinki, Jyvaskyla, Kuopio, Turku
- Életkor
- 18 év and over
- People
- 2787 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-516654-22-00 · EU 2024-516654-22-00 - 3. fázisTaking peopleA Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Helsinki
- Életkor
- Up to 18 év
- People
- 117 worldwide
- Run by
- Bayer
See details and how to joinNCT07192952 · EU 2024-519830-22-00 - 3. fázisTaking peopleA Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
- Where
- Helsinki
- Életkor
- 6 hónap to 17 év
- People
- 111 worldwide
- Run by
- Bayer
See details and how to joinNCT07188805 · EU 2024-519829-38-00 - 3. fázisTaking peopleStudy to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- Where
- Helsinki, Tampere, Turku
- Életkor
- 18 év to 130 év
- People
- 3850 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06307652 · EU 2023-508162-15-00 - No phaseTaking peopleA Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in a Real-world Setting
- Where
- Multiple Locations
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Bayer
See details and how to joinNCT07235462 - No phaseTaking peopleConduction System Pacing vs. Biventricular Pacing for Cardiac Resynchronization Therapy
- Where
- Helsinki
- Életkor
- 18 év to 99 év
- People
- 1100 worldwide
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT07492979 - 3. fázisTaking peopleMYTHS - MYocarditis THerapy With Steroids
- Where
- Helsinki
- Életkor
- 18 év to 69 év
- People
- 288 worldwide
- Run by
- Niguarda Hospital
See details and how to joinNCT05150704 - 2. fázisTaking peopleEffect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
- Where
- Helsinki, Kuopio, Tampere, Turku
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Turku University Hospital
See details and how to joinNCT04696523 - No phaseTaking peopleHFPEF-project: Heart Failure Phenotyping - Exploring the Fingerprints
- Where
- Helsinki
- Életkor
- 18 év to 85 év
- People
- 300
- Run by
- University of Helsinki
See details and how to joinNCT06465043 - No phaseTaking peopleAtrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure
- Where
- Helsinki
- Életkor
- 60 év and over
- People
- 220 worldwide
- Run by
- University Hospital, Geneva
See details and how to joinNCT06207383 - No phaseTaking peopleAtrial Appendage Micrograft Transplants to Assist Heart Repair After Cardiac Surgery
- Where
- Helsinki
- Életkor
- 18 év to 75 év
- People
- 50
- Run by
- Hospital District of Helsinki and Uusimaa
See details and how to joinNCT05632432